Sep 09, 2019 / 06:50PM GMT
David Ryan Lewis - Morgan Stanley, Research Division - MD
Let's go kick it off here as we progress through the afternoon here. We have snacks outside. They're red M&Ms. We can't really figure out why at a Morgan Stanley blue conference we have red M&Ms, but we're going to figure that out eventually.
My name is David Lewis, medical device analyst here at Morgan Stanley. It's my pleasure to have with me one member of management from Nevro, the CEO, Keith Grossman. We're going to jump right into Q&A.
Questions and Answers:
David Ryan Lewis - Morgan Stanley, Research Division - MDKeith, just given your kind of limited tenure with the company, a lot is happening in a very short time there. Probably just kind of catch us up to date on what was the opportunity as you saw when you took the job? And sort of how has that opportunity progressed in these first kind of few short months you've in the business?
D. Keith Grossman - Nevro Corp. - Chairman of the Board, CEO & President
Sure. Well, first
Trustpilot
